Buy Regulus Therapeutics Stock | RGLS Stock Price & Latest News | Public.com
RGLS

Regulus Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View Regulus Therapeutics (RGLS) stock trends here

    About RGLS

    Regulus Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.16
    -0.23
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.10

    Actual EPS
    Q1 2021

    Stats

    Market Cap$76,93M
    Volume4,19k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.97
    1 Year Low$0.42
    Open$1.23
    High$1.26
    Low$1.05

    Buy any stock with any amount of money.

    Download the App
    Download the app